Affinity Asset Advisors »

Corcept Therapeutics Incorporated shares owned by Affinity Asset Advisors

Quarter-by-quarter ownership of Corcept Therapeutics Incorporated (CORT) shares owned by Affinity Asset Advisors from 13F filings

Historical chart of Affinity Asset Advisors investment in Corcept Therapeutics Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Corcept Therapeutics Incorporated held by Affinity Asset Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Corcept Therapeutics Incorporated by Affinity Asset Advisors

Quarter filed Position value Share count Share price at filing
2026-03-31 $2.0M 50k 40.31
2025-03-31 $8.0M 70k 114.22

More positions owned by Affinity Asset Advisors

State Str Spdr S&p 500 Etf T Tr Unit Put Option (SPY)
Apogee Therapeutics (APGE)
Xenon Pharmaceuticals (XENE)
Erasca (ERAS)
Insmed Com Par $.01 (INSM)
Roivant Sciences SHS (ROIV)
Spyre Therapeutics Com New (SYRE)
Centessa Pharmaceuticals Sponsored Ads
Praxis Precision Medicines I Com New (PRAX)
Anaptysbio Inc Common (ANAB)
Alkermes SHS (ALKS)
Cytokinetics Com New (CYTK)
Abivax Sa Sponsored Ads (ABVX)
Teva Pharmaceutical Inds Sponsored Ads (TEVA)
Arcellx Common Stock (ACLX)

View all positions for Affinity Asset Advisors

Top funds holding Corcept Therapeutics Incorporated

BlackRock
Ingalls & Snyder
Renaissance Technologies
Vanguard Portfolio Management
Vanguard Capital Management
Parallel Advisors
State Street Corporation
FMR
Geode Capital Management
First Trust Advisors
Dimensional Fund Advisors
Tang Capital Management
Caption Management
UBS Group
Jane Street

View all funds holding Corcept Therapeutics Incorporated